|
First and
foremost, it is important to realize that Medicare Part D – the
prescription drug benefit – is here -- effective
January 1,
2006.
It redefines much of the way retail pharmacy
operates and the profession of pharmacy. The best thing a
pharmacist can do is be prepared and explore opportunities to make
the most of the changes.
Information
will be regularly added to this website. Plan to check it
regularly!
Medicare Prescription Drug Updates
-
CMS' Part D Reference Document for Pharmacists -
Coventry addresses incorrect copays to prescriptions for dual
eligible institutionalized beneficiaries
-
CMS Posts Part D Plan-Level Enrollment Data (7/28/06)
Friday, July 28, CMS
posted Part D plan-level enrollment data for Medicare Advantage
(MA), Cost, PACE, Demo, and Prescription Drug Plan (PDP) to the
its website. This data reflects enrollment counts that were paid
for the month of July 2006. Please carefully review the
technical notes appearing at the top of the worksheet.
Plan-level data will
be posted once a year during the month following the conclusion
of the MA open enrollment season. Barring any legislative
changes, interested parties can expect the next plan-level
enrollment data in June 2007, following the end of MA enrollment
season on April 30.
All other months of
the year, CMS will post MA and Part D enrollment data at the
contract level. Additionally, CMS will post a summary of
enrollment by organization type.
The Annual Report by
Plan is available in the "downloads" section at:
http://www.cms.hhs.gov/PrescriptionDrugCovGenIn/02_EnrollmentData.asp
-
Message from CMS (7/10/06): Erectile Dysfunction Medications
Q: Are Erectile Dysfunction (ED) drugs
covered under Part D?
A: For Contract Year (CY) 2006 ED drugs
met the definition of a Part D drug and were available on Plan
Sponsor formularies. On October 26, 2005, Section
1860D-2(e)(2)(A) of the Social Security Act (the Act) was
amended excluding from the definition of a Part D drug, “a drug
when used for the treatment of sexual or erectile dysfunction,
unless such drug were used to treat a condition, other than
sexual or erectile dysfunction, for which the drug has been
approved by the Food and Drug Administration (FDA)”.
Subsequently, beginning CY 2007, ED drugs, when prescribed for
the treatment of sexual or erectile dysfunction, will be
excluded from coverage under Part D.
As with other excluded drugs, Part D
sponsors may only continue coverage of ED drugs as long as
they do so as supplemental benefits through enhanced
alternative coverage. In addition, ED drugs will meet the
definition of a Part D drug when prescribed for medically
accepted indications approved by the FDA other than sexual or
erectile dysfunction such as pulmonary hypertension. However,
ED drugs will not meet the definition of a Part D drug for
other off-label uses not approved by the FDA. This includes
non-FDA approved uses included in one of the compendia listed
in section 1927(g)(1)(B)(i) of the Act : American Hospital
Formulary Service Drug Information, United States
Pharmacopeia-Drug Information, and DRUGDEX Information Syste m.
Summer
2006 Edition of "The Pulse of CMS" (6/30/06)
Dr. McClellan announces postponement of the public posting of
AMP (speech from NCPA Legislative Conference) (5/22/06)
CMS Clarification of
Coverage of Prescription Niacin Under Part D (4/11/06)
Third Progress Report on the
Medicare Prescription Drug Benefit. Prepared by Mike
Leavitt, Secretary of Health and Human Services. April 4,
2006.
"Medicare
Prescription Drug Coverage and Your Rights" flier for display
NCOA: Listing of Medicare Part D Resources
Message from CMS (3/1/06):
March 1 is here.... plan for new enrollees and plan switchers
In the next
few days, pharmacists will inevitably have to serve some
Medicare beneficiaries who have enrolled in a plan or switched
plans late in February. As a result, some of these beneficiaries
may not yet be identified in pharmacy systems. As a reminder to
pharmacists, we are once again sending instructions for using
the eligibility (E1) functionality to check on plan enrollment
and Medicare eligibility status. Per-Se Technologies has issued
recommendations
for optimizing the E1. For more information you may visit their
Medicare Part D
home page,
or contact your software vendor. For beneficiaries who are
eligible for both Medicare and Medicaid but who do not appear to
have been enrolled in a plan, we are also sending instructions
for using the Point of Sale Facilitated enrollment process. This
process, known as the "Wellpoint Point of Sale solution," will
allow pharmacies to submit claims to Wellpoint for a dual
eligible beneficiary who does not appear to be enrolled in a
plan so the beneficiary will not have to leave the pharmacy
without the medications they need. An
FAQ document
and
instructions,
can be found at Anthem Prescription's Part D
home page.
-
MEDICARE MODERNIZATION ACT 2007 DRAFT GUIDELINES - FORMULARIES:
CMS Strategy for Affordable Access to Comprehensive Drug
Coverage. Guidelines for Reviewing Prescription Drug
Plan Formularies and Procedures
-
Draft Transition Process Requirements for Part D Sponsors
February 2006
-
What do I
need to know about Medicare prescription drug coverage to help
my homeless clients?
-
CMS Memo:
Public Comment Period for Draft 2007 MA, MA-PD and PDP Call
Letters (2/21/06)
-
CMS Memo:
Public Comment Period for Draft 2007 MA,
MA-PD and PDP Call Letters
(2/21/06)
-
CMS
Memo: Long-Term Care Pharmacy Claims Transactions (2/16/06).
The link referenced in this document is
especially useful for LTC pharmacy billing departments (http://www.ncpdp.org/frame_news_hipaa_trans.htm)
Click on "Version 5 Editorial" the
LTC Appendix F begins on P. 184 of the Version 5, Editorial
Update.
-
CMS
Memo: Premium Withhold Processing (2/16/06)
-
Part D Drugs/Part D Excluded Drugs (2/7/06)
-
Model Coverage Determination Request Form (2/8/06)
-
CMS Memo: 30 Day Billing Limit for Pharmacists and Beneficiaries
(2/7/06)
-
CMS
Memo: Prescription Niacin Products (2/3/06) (Note:
Superseded by 4/11/06 notice)
-
CMS
Memo: Extension of Transition Period to March 31 (2/2/06)
-
One Month Progress Report on
the Medicare Prescription Drug Benefit. Prepared by Mike
Leavitt, Secretary of Health and Human Services. February 1,
2006.
-
State Fact Sheet
(1/19/06)
-
Wellpoint Point of Sale Fact Sheet
-
POS Facilitated
Enrollment: Pharmacy Q&As (1/18/06)
-
CMS Memo, January 13,
2006
-
Quick Answers to FAQs
on Processing Claims for Dual Eligible Beneficiaries
-
For CSR
describing the POS “WellPoint” process to a pharmacy
-
CMS Transition Policy Letter for January 6, 2006
-
CMS
Pharmacy Transition Policies (1/6/06)
-
CMS
Information to Assist Pharmacists in Completing Pharmacy
Transactions (1/4/06)
-
CMS Pharmacist Help Letter to Plans, January 4, 2006
-
What If
Scenarios: Medicare & Medicaid Full Benefit Dual Eligibles
-
Quick Answers
to FAQs on Processing Claims for Dual Eligible Beneficiaries
-
Virginia Medicaid Prior Authorization Criteria
-
Virginia Medicaid Coverage Request Fax Form
-
POS Facilitated Enrollment: Update
on NACDS Issues,
WellPoint/CMS (12/30/05)
-
MA-PD
Transition Policy (12/29/05)
-
Listing of Part D Approved Contract Pharmacy Network Contacts by
State and Legal Entity Name
-
Crosswalk for Auto Enroll Plans Phone, BIN, PCN
-
Q&A POS Solutions (12/28/05)
-
PDP
Transition Policy (12/27/05)
-
Point-of-Sale Facilitated Enrollment of Dual Beneficiaries
Medicare Part D/B
Helpful Documents
CCRx Memos
Humana Bulletins
What each and every pharmacist should do -
Six Key Steps
1) Be
prepared -- Focus on learning as much as possible about the
Benefit. You only have a few days – so start NOW!
-
Go to CMS
website with
Information for Providers. Read the articles in the
Drug Coverage Series. They are relatively short - 2 to
3 pages.
-
Visit the CMS specific section for
Pharmacists.
-
CMS has
posted additional information about the new benefit including an
educational video tool specifically for pharmacists that can help
answer questions about implementation. The video tool as well as
additional information is now available on the CMS website (http://new.cms.hhs.gov/PrescriptionDrugCovGenIn/).
The video covers details on the new E1 eligibility transaction,
instructions on billing for Katrina evacuees and facilitated point
of sale enrollment of dual eligibles, as well as other pharmacy
related topics of interest.
-
Save this list
of
key terminology to help you understand the benefit
-
The Pennsylvania Pharmacists Association has added an
additional list of key terminology.
-
Here is a list
of terms to help in talking to patients about the
Part D Benefit.
-
CMS offers an acronym search engine
here.
-
VPhA has a list of
continuing education
courses so you can earn CE while learning
about the benefit.
-
Bookmark
key websites. So you can check for additional information
frequently.
-
Frequently Asked Questions
are available from CMS that are updated frequently.
-
Consider participating in CMS Open Forums to hear from and ask
questions of CMS leadership on topics of interest to your particular
provider type; for information about these forums visit
http://new.cms.hhs.gov/OpenDoorForums/.
-
Sign-up to receive email notification of new information for
pharmacies and pharmacists about the Medicare Modernization Act and Medicare
Prescription Drug Coverage.
Click here for access and to sign up for the CMS mailing list.
2) Specifically
understand the low income benefit and promote it to seniors who
may qualify. Seniors who may qualify for this need to apply
NOW!
3) Determine to what extent your pharmacy might be ready and
interested in providing Medication Therapy Management Services (MTMS).
4) Work
with your Medicare eligible patients to promote plans that will work for both
them and your pharmacy.
Overall
Fact Sheet for Beneficiaries
Low Income Application (provided with the notices mailed out -
per section 2 above)
Promotional Opportunities - Posters titled
"Have Low
Income? Social Security Can Help with Prescription Costs" can be ordered
free of charge on the Centers for Medicare and Medicaid Services (CMS) website.
The posters direct Medicare beneficiaries with low income to a toll free
number where they can find out if they are eligible for help with prescription drug
costs. The posters are suitable for display in a pharmacy, Order the size and style
appropriate for your use. To view and order
the posters, go to
http://www.cms.hhs.gov/medlearn/drugcoverage.asp on the CMS website.
Review the scripts being used by
1-800-MEDICARE. These scripts are posted for your reference and to understand what call center
customer service representatives are telling beneficiaries. As the scripts are modified,
updates will be posted to this website. You can find the scripts at
http://new.cms.hhs.gov/partnerships/downloads/scripts.pdf
on the CMS website.
5)
Get your NPI as an individual
pharmacist
-
CMS is pleased
to announce the availability of a new identifier for use in the
standard electronic health care transactions. The National
Provider Identifier (NPI) will be the single provider identifier, replacing the different
provider identifiers currently in use for each health plan with which they do business. Obtaining
the NPI is required in the Health Insurance Portability and Accountability Act of
1996 (HIPAA) and will be the single national provider identifier for pharmacists, pharmacies,
and prescribers no later than May 23, 2007.
National standards for electronic health care
transactions encourage electronic commerce in the health care industry and simplify
the processes involved to reduce the administrative burdens on health care providers. A
May 6th letter (linked below) was distributed to aid in understanding the background
of this requirement & what steps are necessary to apply for and receive your NPI.
http://www.cms.hhs.gov/hipaa/hipaa2/npi_provider.asp
or go directly
to
https://nppes.cms.hhs.gov/
Obtaining your NPI is recommended for individual pharmacists now.
Pharmacies may wish to hold off on this process
-
Pharmacists:
The NPI is the
first opportunity for pharmacists to have an individual provider number with which to bill third parties.*
This includes billing prescription drug plans (PDPs) for medication therapy management
services (MTMS) under the Medicare Part D drug benefit. Pharmacists are encouraged to
obtain an individual NPI. This is a new opportunity for pharmacists. The provider
identifier number does not guarantee that payment will be provided, but may be required by
payers in the future.
-
Pharmacies:
For
pharmacies, the NPI will replace all other provider identifiers,
for example, such as the NCPDP pharmacy ID number,
formerly the NABP number presently required by health plans.
Before you pursue a NPI for your
pharmacy, you should be aware of an upcoming initiative by the National
Council for Prescription Drug Programs (NCPDP). Under NCPDP’s guidance, the pharmacy
industry is currently developing a transition plan to move pharmacies from the NCPDP
number to the NPI over the next two years. NCPDP plans to submit its application to CMS
to be a bulk NPI enumerator in late summer. Once its application is approved, NCPDP
will contact pharmacies and request authorization to become their agent in obtaining
their NPI. NCPDP will then work with CMS and obtain NPIs for all authorizing pharmacies no
later than May 2006, giving processors and pharmacies a full year to test and implement
the NPI before the required implementation date of May 23, 2007. NCPDP
requests that you delay your pharmacy’s application for an NPI until this fall when NCPDP
has been certified to obtain NPIs on behalf of pharmacies. If you authorize NCPDP to obtain a
NPI on behalf of your pharmacy, your new NPI and current NCPDP number will automatically
be disseminated to the pharmacy industry (including payers). This will ensure your
claims process normally with minimal disruption. NCPDP will not charge any fees for its
enumeration activities on your behalf. For more information on this initiative, visit
http://www.ncpdp.org
or read this
NPI Enumeration update
(added 12/7/05)
from NCPDP.
-
Pharmacies and individual pharmacists are advised in
CMS’s NPI letter not to use the NPI until health plans and PDPs have issued specific
instructions on accepting the NPI, which could begin prior to but no later than May 23,
2007.
-
Beginning May 1, 2006, the
Centers for Medicare & Medicaid Services (CMS) announces the
capability for health industry organizations to submit health
care providers' applications for National Provider Identifiers (NPIs)
to the National Plan and Provider Enumeration System (NPPES) via
Electronic File Interchange (EFI). With EFI, a CMS-approved
health industry organization can submit a health care provider's
NPI application data, along with the application data of many
other health care providers, in a single electronic file in a
CMS-specified format.
EFI is an alternative to health care providers having to apply
for their NPIs via the web-based or paper application process.
After the NPPES processes a file, it makes available to the
organization a downloadable file containing the NPIs of the
enumerated health care providers. Interested health industry
organizations should avail themselves of the EFI materials
available from the CMS NPI page (www.cms.hhs.gov/NationalProvIdentStand/)
and from the NPPES page (https://nppes.cms.hhs.gov) before
downloading and completing the Certification Statement
(available at https://nppes.cms.hhs.gov) and registering as EFI
Organizations. A completed Certification Statement must be
approved by CMS before an interested health industry
organization can participate in EFI.
6) Medicare
Updates
-
July 25, 2007 NEW
-
July 13, 2007
-
July 11, 2007
-
July 6, 2007
-
July 2, 2007
-
June 18, 2007
-
June 12, 2007
-
May 30, 2007
-
May 24, 2007
-
May 21, 2007
-
May 15, 2007
-
May 14, 2007
-
April 19, 2007
-
April 17, 2007
-
April 4, 2007
-
April 2, 2007
-
March 23, 2007
-
March 22, 2007
-
February 13, 2007
-
February 8, 2007
-
January
31, 2007
-
January 1, 2007
-
December 22, 2006
-
December 20, 2006
-
December 12, 2006
-
December 1, 2006
-
November 27, 2006
-
November 15, 2006
-
November 6, 2006
-
October
26, 2006
-
October
16,
2006
-
October 6,
2006
-
September
29,
2006
-
September
14,
2006
-
September
12,
2006
-
September
1,
2006
-
July 26,
2006
-
June 30,
2006
-
June 20,
2006
-
June 14,
2006
-
June 9,
2006
-
May 26,
2006
-
May 25,
2006
-
May 22,
2006
-
May 15,
2006
-
May 11,
2006
-
May 9,
2006
-
April 21,
2006
-
April 19,
2006
-
April 7,
2006
-
April 4, 2006
-
March 31, 2006
-
March 24, 2006
-
March 21, 2006
-
March 2, 2006
-
March 1, 2006
-
February
13, 2006
-
February 2, 2006
-
January 28, 2006
-
January 20, 2006
-
January 17, 2006
-
January 11, 2006
-
January 9, 2006
-
December 30, 2005
-
December 2, 2005
-
December 1, 2005
-
November 23, 2005
-
November 15, 2005
-
October 14, 2005
-
October 7, 2005
-
September 27,
2005
-
September 2, 2005
-
August
29,
2005
-
August 15,
2005
-
August 9, 2005
-
Plan
Benchmark Fact Sheet (Final)
-
July 29, 2005
-
June 28, 2005
-
June 17, 2005
-
June 10, 2005
-
June 2, 2005
-
Access to
Benefits Coalition Statement
-
May 31, 2005
-
May 27, 2005
-
May 23, 2005
-
May 9, 2005
Patient
Assistance Programs
On Wednesday, the Centers for
Medicare & Medicaid Services posted on its website guidance
outlining how pharmaceutical
company patient assistance programs can work with Medicare Part D
in light of a recent Office of the Inspector General Bulletin
(November 22, 2005).
There is nothing in the law that
prohibits a pharmaceutical company from making a patient
assistance program available to Medicare beneficiaries -- even
beneficiaries who have enrolled in a Part D plan.
The decision to keep
a patient assistance program, as well as the terms of the program,
are up to the pharmaceutical company, not the US government.
However, any assistance provided to a Part D enrollee must be
clearly outside of the Medicare Part D program
and would not
count as Part D "true out-of-pocket" spending by the beneficiary.
CMS will work with companies interested in entering into a
voluntary data sharing arrangement with CMS, in accordance with
the OIG guidance, to facilitate coordination of benefits.
Pharmaceutical companies also have the option to make cash
donations to bona fide, independent charities that assist Medicare
beneficiaries with out-of-pocket drug expenses.
CMS understands the value that
pharmaceutical patient assistance programs provide to many
financially needy individuals, including those with Medicare.
Individuals currently without drug coverage who are eligible for
Medicare should consider enrolling in a Medicare prescription drug
plan that meets their needs. In addition, beneficiaries who think
they may be eligible for extra help may file an application with
the Social Security Administration for the Part D limited-income
subsidy. These steps will ensure that people have access to the
prescriptions they need.
The guidance, which
provides more detail about
this issue, as well as an example of how this would work for a
Medicare beneficiary can be accessed by clicking on the link
below.
http://www.cms.hhs.gov/PrescriptionDrugCovGenIn/05_Pharma.asp#TopOfPage
Provider Update
Also, attached is a letter from
HHS' Physicians' Regulatory Issues Team with valuable information
for providers about how to assist beneficiaries with appeals,
coverage determinations and exceptions as well as other general
information about Medicare Prescription Drug Coverage.
Providers Letter
Your feedback is needed!
Tell us what else you need to know about Medicare. |